{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:47:12Z","timestamp":1791362832181,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022221","name":"Sickkids Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00467-024-06605-0","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T07:13:06Z","timestamp":1732259586000},"page":"1625-1634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study"],"prefix":"10.1007","volume":"40","author":[{"given":"Cal H.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nowrin","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonny","family":"Banh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Brooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaneet","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlene","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Noone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Wei","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovanka H.","family":"Vasilevska-Ristovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulan S.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"6605_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(18)30536-1","journal-title":"Lancet"},{"key":"6605_CR2","doi-asserted-by":"publisher","unstructured":"Veltkamp F, Rensma LR, Bouts AHM, LEARNS consortium (2021) Incidence and Relapse of idiopathic nephrotic syndrome: meta-analysis. Pediatrics 148:e2020029249. https:\/\/doi.org\/10.1542\/peds.2020-029249","DOI":"10.1542\/peds.2020-029249"},{"key":"6605_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma PK et al (2012) Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr 49:881\u2013887. https:\/\/doi.org\/10.1007\/s13312-012-0220-4","journal-title":"Indian Pediatr"},{"key":"6605_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3109\/0886022X.2015.1010940","volume":"37","author":"SG \u00d6zl\u00fc","year":"2015","unstructured":"\u00d6zl\u00fc SG, Demircin G, T\u00f6kmeci N et al (2015) Long-term prognosis of idiopathic nephrotic syndrome in children. Ren Fail 37:672\u2013677. https:\/\/doi.org\/10.3109\/0886022X.2015.1010940","journal-title":"Ren Fail"},{"key":"6605_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ekir.2019.12.015","volume":"5","author":"SA Carter","year":"2020","unstructured":"Carter SA, Mistry S, Fitzpatrick J et al (2020) Prediction of short- and long-term outcomes in childhood nephrotic syndrome. Kidney Int Rep 5:426\u2013434. https:\/\/doi.org\/10.1016\/j.ekir.2019.12.015","journal-title":"Kidney Int Rep"},{"key":"6605_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00467-020-04684-3","volume":"36","author":"S Khullar","year":"2021","unstructured":"Khullar S, Banh T, Vasilevska-Ristovska J et al (2021) Impact of steroids and steroid-sparing agents on quality of life in children with nephrotic syndrome. Pediatr Nephrol 36:93\u2013102. https:\/\/doi.org\/10.1007\/s00467-020-04684-3","journal-title":"Pediatr Nephrol"},{"key":"6605_CR7","doi-asserted-by":"publisher","unstructured":"(1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A report of the international study of kidney disease in children. Kidney Int 20:765\u2013771. https:\/\/doi.org\/10.1038\/ki.1981.209","DOI":"10.1038\/ki.1981.209"},{"key":"6605_CR8","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2215\/CJN.00380116","volume":"11","author":"THM Banh","year":"2016","unstructured":"Banh THM, Hussain-Shamsy N, Patel V et al (2016) Ethnic differences in incidence and outcomes of childhood nephrotic syndrome. Clin J Am Soc Nephrol 11:1760\u20131768. https:\/\/doi.org\/10.2215\/CJN.00380116","journal-title":"Clin J Am Soc Nephrol"},{"key":"6605_CR9","doi-asserted-by":"publisher","first-page":"CD002290","DOI":"10.1002\/14651858.CD002290.pub5","volume":"4","author":"NG Larkins","year":"2020","unstructured":"Larkins NG, Liu ID, Willis NS et al (2020) Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 4:CD002290. https:\/\/doi.org\/10.1002\/14651858.CD002290.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"6605_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J et al (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"6605_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00467-011-1825-x","volume":"26","author":"A Zagury","year":"2011","unstructured":"Zagury A, de Oliveira AL, de Moraes CAP et al (2011) Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:915\u2013920. https:\/\/doi.org\/10.1007\/s00467-011-1825-x","journal-title":"Pediatr Nephrol"},{"key":"6605_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.ajkd.2007.02.270","volume":"49","author":"HAC Kyrieleis","year":"2007","unstructured":"Kyrieleis HAC, Levtchenko EN, Wetzels JFM (2007) Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 49:592\u2013597. https:\/\/doi.org\/10.1053\/j.ajkd.2007.02.270","journal-title":"Am J Kidney Dis"},{"key":"6605_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/ndt\/gfq405","volume":"26","author":"B Cammas","year":"2011","unstructured":"Cammas B, Harambat J, Bertholet-Thomas A et al (2011) Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Nephrol Dial Transplant 26:178\u2013184. https:\/\/doi.org\/10.1093\/ndt\/gfq405","journal-title":"Nephrol Dial Transplant"},{"key":"6605_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00467-011-1830-0","volume":"26","author":"S Azib","year":"2011","unstructured":"Azib S, Macher MA, Kwon T et al (2011) Cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:927\u2013932. https:\/\/doi.org\/10.1007\/s00467-011-1830-0","journal-title":"Pediatr Nephrol"},{"key":"6605_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2369-14-25","volume":"14","author":"N Hussain","year":"2013","unstructured":"Hussain N, Zello JA, Vasilevska-Ristovska J et al (2013) The rationale and design of Insight into nephrotic syndrome: investigating genes, health and therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome. BMC Nephrol 14:25. https:\/\/doi.org\/10.1186\/1471-2369-14-25","journal-title":"BMC Nephrol"},{"key":"6605_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"6605_CR17","first-page":"423","volume":"2","author":"ISKDC","year":"1974","unstructured":"ISKDC (1974) Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the international study of kidney disease in children. Lancet 2:423\u2013427","journal-title":"Lancet"},{"key":"6605_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4:481\u2013508. https:\/\/doi.org\/10.2215\/CJN.04800908","journal-title":"Clin J Am Soc Nephrol"},{"key":"6605_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ncpneph0225","volume":"2","author":"P Liptak","year":"2006","unstructured":"Liptak P, Ivanyi B (2006) Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2:398\u2013404. https:\/\/doi.org\/10.1038\/ncpneph0225. (quiz following 404)","journal-title":"Nat Clin Pract Nephrol"},{"key":"6605_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0971-4065.107197","volume":"23","author":"A Sinha","year":"2013","unstructured":"Sinha A, Sharma A, Mehta A et al (2013) Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome. Indian J Nephrol 23:41\u201346. https:\/\/doi.org\/10.4103\/0971-4065.107197","journal-title":"Indian J Nephrol"},{"key":"6605_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2215\/CJN.01320406","volume":"2","author":"N Kambham","year":"2007","unstructured":"Kambham N, Nagarajan S, Shah S et al (2007) A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2:135\u2013142. https:\/\/doi.org\/10.2215\/CJN.01320406","journal-title":"Clin J Am Soc Nephrol"},{"key":"6605_CR22","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https:\/\/doi.org\/10.1542\/peds.2017-1904","journal-title":"Pediatrics"},{"key":"6605_CR23","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Mu\u00f1oz A, Ng DK et al (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956. https:\/\/doi.org\/10.1016\/j.kint.2020.10.047","journal-title":"Kidney Int"},{"key":"6605_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0140-6736(70)90108-x","volume":"2","author":"TM Barratt","year":"1970","unstructured":"Barratt TM, Soothill JF (1970) Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 2:479\u2013482. https:\/\/doi.org\/10.1016\/s0140-6736(70)90108-x","journal-title":"Lancet"},{"key":"6605_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0022-3476(73)80585-2","volume":"82","author":"J Chiu","year":"1973","unstructured":"Chiu J, McLaine PN, Drummond KN (1973) A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 82:607\u2013613. https:\/\/doi.org\/10.1016\/S0022-3476(73)80585-2","journal-title":"J Pediatr"},{"key":"6605_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bmj.4.5935.7","volume":"4","author":"JS Cameron","year":"1974","unstructured":"Cameron JS, Chantler C, Ogg CS, White RH (1974) Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. Br Med J 4:7\u201311. https:\/\/doi.org\/10.1136\/bmj.4.5935.7","journal-title":"Br Med J"},{"key":"6605_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004670000523","volume":"16","author":"K Latta","year":"2001","unstructured":"Latta K, von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271\u2013282. https:\/\/doi.org\/10.1007\/s004670000523","journal-title":"Pediatr Nephrol"},{"key":"6605_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00856817","volume":"6","author":"P Niaudet","year":"1992","unstructured":"Niaudet P (1992) Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 6:1\u20133. https:\/\/doi.org\/10.1007\/BF00856817","journal-title":"Pediatr Nephrol"},{"key":"6605_CR29","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","volume":"23","author":"EM Dorresteijn","year":"2008","unstructured":"Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN et al (2008) Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 23:2013\u20132020. https:\/\/doi.org\/10.1007\/s00467-008-0899-6","journal-title":"Pediatr Nephrol"},{"key":"6605_CR30","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L et al (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689\u20131697. https:\/\/doi.org\/10.1681\/ASN.2012121200","journal-title":"J Am Soc Nephrol"},{"key":"6605_CR31","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1093\/ndt\/gfq318","volume":"25","author":"K Ishikura","year":"2010","unstructured":"Ishikura K, Yoshikawa N, Hattori S et al (2010) Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome. Nephrol Dial Transplant 25:3956\u20133962. https:\/\/doi.org\/10.1093\/ndt\/gfq318","journal-title":"Nephrol Dial Transplant"},{"key":"6605_CR32","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","volume":"27","author":"W Wang","year":"2012","unstructured":"Wang W, Xia Y, Mao J et al (2012) Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol 27:2073\u20132079. https:\/\/doi.org\/10.1007\/s00467-012-2228-3","journal-title":"Pediatr Nephrol"},{"key":"6605_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s004670050558","volume":"13","author":"Y Inoue","year":"1999","unstructured":"Inoue Y, Iijima K, Nakamura H, Yoshikawa N (1999) Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 13:33\u201338. https:\/\/doi.org\/10.1007\/s004670050558","journal-title":"Pediatr Nephrol"},{"key":"6605_CR34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/ki.2008.24","volume":"73","author":"K Ishikura","year":"2008","unstructured":"Ishikura K, Ikeda M, Hattori S et al (2008) Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney Int 73:1167\u20131173. https:\/\/doi.org\/10.1038\/ki.2008.24","journal-title":"Kidney Int"},{"key":"6605_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","volume":"172","author":"B Basu","year":"2018","unstructured":"Basu B, Sander A, Roy B et al (2018) Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial. JAMA Pediatr 172:757\u2013764. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.1323","journal-title":"JAMA Pediatr"},{"key":"6605_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5114\/aoms\/145587","volume":"18","author":"L Wang","year":"2022","unstructured":"Wang L, Zhu J, Xia M et al (2022) Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing\/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life. Arch Med Sci 18:275\u2013278. https:\/\/doi.org\/10.5114\/aoms\/145587","journal-title":"Arch Med Sci"},{"key":"6605_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12519-015-0062-y","volume":"12","author":"EM Yang","year":"2016","unstructured":"Yang EM, Lee ST, Choi HJ et al (2016) Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell\u00ae, a generic formula. World J Pediatr 12:60\u201365. https:\/\/doi.org\/10.1007\/s12519-015-0062-y","journal-title":"World J Pediatr"},{"key":"6605_CR38","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2215\/CJN.00110112","volume":"7","author":"K Ishikura","year":"2012","unstructured":"Ishikura K, Yoshikawa N, Nakazato H et al (2012) Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children. Clin J Am Soc Nephrol 7:1576\u20131583. https:\/\/doi.org\/10.2215\/CJN.00110112","journal-title":"Clin J Am Soc Nephrol"},{"key":"6605_CR39","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","volume":"20","author":"A El-Husseini","year":"2005","unstructured":"El-Husseini A, El-Basuony F, Mahmoud I et al (2005) Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol Dial Transplant 20:2433\u20132438. https:\/\/doi.org\/10.1093\/ndt\/gfi059","journal-title":"Nephrol Dial Transplant"},{"key":"6605_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/phar.2749","volume":"43","author":"X Mo","year":"2023","unstructured":"Mo X, Chen X, Zeng H et al (2023) Tacrolimus in the treatment of childhood nephrotic syndrome: machine learning detects novel biomarkers and predicts efficacy. Pharmacotherapy 43:43\u201352. https:\/\/doi.org\/10.1002\/phar.2749","journal-title":"Pharmacotherapy"},{"key":"6605_CR41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.V74543","volume":"7","author":"MJ Gregory","year":"1996","unstructured":"Gregory MJ, Smoyer WE, Sedman A et al (1996) Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. J Am Soc Nephrol 7:543\u2013549","journal-title":"J Am Soc Nephrol"},{"key":"6605_CR42","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1046\/j.1523-1755.2002.00303.x","volume":"61","author":"K Iijima","year":"2002","unstructured":"Iijima K, Hamahira K, Tanaka R et al (2002) Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61:1801\u20131805. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00303.x","journal-title":"Kidney Int"},{"key":"6605_CR43","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2215\/CJN.01520209","volume":"4","author":"S Kengne-Wafo","year":"2009","unstructured":"Kengne-Wafo S, Massella L, Diomedi-Camassei F et al (2009) Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol 4:1409\u20131416. https:\/\/doi.org\/10.2215\/CJN.01520209","journal-title":"Clin J Am Soc Nephrol"},{"key":"6605_CR44","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/adc.2005.080960","volume":"91","author":"S Fujinaga","year":"2006","unstructured":"Fujinaga S, Kaneko K, Muto T et al (2006) Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 91:666\u2013670. https:\/\/doi.org\/10.1136\/adc.2005.080960","journal-title":"Arch Dis Child"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06605-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06605-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06605-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:32:39Z","timestamp":1743276759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06605-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6605"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06605-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research ethics approval for INSIGHT was obtained from The Hospital for Sick Children (Toronto, Canada). Informed consent for the study was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research ethics and consent"}},{"value":"All authors declare no real or perceived conflicts of interest that could affect the study design, collection, analysis and interpretation of data, writing of the report, or the decision to submit for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}